Literature DB >> 16113805

Diagnostic strategy using a modified clinical decision rule and D-dimer test to rule out pulmonary embolism in elderly in- and outpatients.

Maaike Söhne1, Pieter W Kamphuisen, Patricia J W B van Mierlo, Harry R Büller.   

Abstract

Excluding or confirming pulmonary embolism remains a diagnostic challenge. In elderly patients pulmonary embolism is associated with substantial co-morbidity and mortality, and many elderly patients with suspected pulmonary embolism are inpatients. The safety and efficacy of the combination of a clinical probability (CDR) and d-dimer test in excluding pulmonary embolism in this group is unclear. We retrospectively analysed data of two prospective studies of consecutive in-and outpatients with suspected pulmonary embolism. The patients were categorized into three age groups: <65 years, 65-75 years and >75 years. The sensitivity, negative predictive value and the proportion of patients with the combination of a non-high CDR score according to Wells (< or = 4) and a normal d-dimer result were calculated for each group. In 747 consecutive patients with suspected pulmonary embolism, sensitivity and negative predictive value of a non-high CDR and a normal d-dimer result in outpatients (n=538) of all age categories (<65 years, 65-75 years and >75 years) were both 100%. These tests were, however, less reliable for inpatients(n=209), irrespective of their age (sensitivity 91% [ CI: 79-98%], negative predictive value 88 % [CI: 74-96%]. The proportion of both in-and outpatients >75 years with a non-high CDR and a normal d-dimer concentration was only 14%, whereas this was 22% in patients 65-75 years and 41% among in-and outpatients <65 years, respectively. In elderly outpatients the combination of a non-high CDR and a normal d-dimer result is a safe strategy to rule out pulmonary embolism. However, in inpatients this algorithm is not reliable to safely exclude pulmonary embolism. In addition, the proportion of patients >65 years in which this strategy excludes pulmonary embolism is markedly lower compared to younger patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113805     DOI: 10.1160/TH04-11-0753

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

Review 1.  Acute pulmonary embolism. Part 1: epidemiology and diagnosis.

Authors:  Renée A Douma; Pieter W Kamphuisen; Harry R Büller
Journal:  Nat Rev Cardiol       Date:  2010-07-20       Impact factor: 32.419

2.  D-dimer for the diagnosis of acute venous thromboembolism in the emergency department: a Janus-face marker.

Authors:  Roberto Manfredini
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 3.  D-dimer test for excluding the diagnosis of pulmonary embolism.

Authors:  Fay Crawford; Alina Andras; Karen Welch; Karen Sheares; David Keeling; Francesca M Chappell
Journal:  Cochrane Database Syst Rev       Date:  2016-08-05

4.  Capnometry in suspected pulmonary embolism with positive D-dimer in the field.

Authors:  Tadeja Hernja Rumpf; Miljenko Krizmaric; Stefek Grmec
Journal:  Crit Care       Date:  2009-12-08       Impact factor: 9.097

5.  Accuracy of D-Dimers to Rule Out Venous Thromboembolism Events across Age Categories.

Authors:  G Der Sahakian; Y E Claessens; J C Allo; J Kansao; G Kierzek; J L Pourriat
Journal:  Emerg Med Int       Date:  2010-07-27       Impact factor: 1.112

6.  Risk-adapted management of acute pulmonary embolism: recent evidence, new guidelines.

Authors:  Anja Käberich; Simone Wärntges; Stavros Konstantinides
Journal:  Rambam Maimonides Med J       Date:  2014-10-29

7.  Age-Adjusted D-Dimer in the Prediction of Pulmonary Embolism: Does a Normal Age-Adjusted D-Dimer Rule Out PE?

Authors:  Jacob Ortiz; Rabia Saeed; Christopher Little; Saul Schaefer
Journal:  Biomed Res Int       Date:  2017-10-19       Impact factor: 3.411

Review 8.  Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation.

Authors:  Luca Masotti; Patrick Ray; Marc Righini; Gregoire Le Gal; Fabio Antonelli; Giancarlo Landini; Roberto Cappelli; Domenico Prisco; Paola Rottoli
Journal:  Vasc Health Risk Manag       Date:  2008
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.